DIRS.INFO The most relevant business & tech news

All four drugs are in a class of wildly popular weight loss drugs known as GLP-1s. In the United Kingdom, authorities last year seized hundreds of counterfeit Ozempic pens — insulin pens that had been relabeled as Ozempic. Counterfeit weight loss drugs have serious health risks, according to the pharmaceutical companies and federal officials. Counterfeiters are already trying to cash in on a weight loss drug that the company hasn't even put on the market yet: retatrutide. But it's also one of the epicenters of the lucrative counterfeit drug trade, according to U.S. authorities who track counterfeit drugs.

Persons: It's, —, Eli Lilly's Mounjaro, they've, Laver, Andy Morling, CNBC Morling, Eli Lilly, Daniel Skovronsky, Eli Lilly's, we'll, Skovronksy, John F, Sal Ingrassia, Ingrassia, Customs isn't, we've, Yoav Keren, GLP, TikTok, Keren, BrandShield, it's, Nicole Johnson, CNBC Johnson, Johnson, Mike Doustdar, Doustdar, Direnc Bada Organizations: CNBC, U.S, Laver Beauty, DHL, Novo Nordisk, Laver, Medicines, Healthcare Products Regulatory Agency, Lilly Research Labs, Kennedy International, JFK International Mail Facility, U.S . Customs, Border Protection, JFK, CBP, Protection, CNBC CNBC, FDA, Customs, Meta, Facebook, World Health Organization, U.S ., Intellectual, Coordination Center, National, Turkish National Police, Novo Nordisk's, CNBC Counterfeiters, CNBC FDA Locations: BOULDER, COLO, Boulder, Ozempic, Shijiazhuang, China, Beijing, Englewood Cliffs , New Jersey, United Kingdom, London, New York City, U.S, Turkey, Europe, South America, United States, India, Mexico, Istanbul, Zurich

☆ Port strike fallout: Blockbuster weight-loss drug supply from Wegovy to Ozempic, Mounjaro, Zepbound caught up in East Coast trade shutdown
▼ + stars: | 2024-10-01 | by ( Lori Ann Larocco | ) www.cnbc.com time to read: +3 min

In this article LLYNOVO.B-DK Follow your favorite stocks CREATE FREE ACCOUNTAn Eli Lilly & Co. Zepbound injection pen, March 28, 2024. Bills of lading, the digital receipts of freight containers, show that the delivery mechanisms for insulin and weight-loss drugs rely on East Coast ports for incoming trade. "Novo Nordisk and Eli Lilly are both heavily reliant on the Port of Norfolk," said William George, director of Research at ImportGenius, which tracks the customs data. Vials on the Wegovy line at the Novo Nordisk A/S production facilities in Hillerod, Denmark, on Friday, March 8, 2024. Bloomberg | Bloomberg | Getty ImagesAn Eli Lilly spokesperson said it does not discuss the details of its external supplier relationships.

Persons: Eli Lilly, Eli Lilly — Ozempic, William George, George, Dennis Monts Organizations: Bloomberg, Getty, Novo Nordisk, ILA, Nordisk, Research, U.S . Senate, CNBC, Nuco Logistics Locations: New England, Texas, U.S, lading, East Coast, Port of Norfolk, ImportGenius, Norfolk, airfreight, Hillerod, Denmark, Monts

☆ CNBC Daily Open: All key data is in — and it's made the Fed's policy path more uncertain
▼ + stars: | 2024-09-13 | by ( Yeo Boon Ping | ) www.cnbc.com time to read: +2 min

CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. Last Friday, the August employment report showed the number of jobs added was lower than expected but higher than the previous month. Wednesday's CPI report showed the lowest 12-month inflation rate in two-and-a-half years. In short, the data hasn't cleared up whether the Fed will cut by 25 or 50 basis points. They think there's a 57% chance of a 25 point cut and 43% of a 50 point one, according to the CME FedWatch tool.

Persons: Stefani Reynolds, We've, Wednesday's, Jeff Cox, Pia Singh, Sarah Min Organizations: Eccles Federal Reserve, Bloomberg, CNBC, U.S . Federal Reserve, PPI Locations: Washington ,

☆ Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
▼ + stars: | 2024-07-30 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +5 min

George Frey | ReutersAn older, once-daily drug for diabetes and obesity from Novo Nordisk called liraglutide may slow the progression of Alzheimer's disease by protecting patients' brains, according to data from a mid-stage trial released on Tuesday. Novo Nordisk sells liraglutide as a diabetes and obesity drug under the brand names Victoza and Saxenda, respectively. Alzheimer's disease often causes the brain to shrink as the illness progresses because crucial nerve cells break down and stop working properly. By 2050, the number of Alzheimer's patients is projected to rise to almost 13 million in the U.S. The ongoing EVOKE is examining semaglutide, the active ingredient in Wegovy and Ozempic, in nearly 2,000 Alzheimer's patients.

Persons: George Frey, Eli Lilly, liraglutide, Brian B, Bettencourt, Heather Snyder, Leqembi, Snyder, Dr, Paul Edison, Edison, Bobby Pugh, Bessie Pugh, Karen Pulfer Focht Organizations: Novo Nordisk Pharmaceutical, Reuters, Novo Nordisk, Imperial College London, Alzheimer's Association International Conference, Toronto Star, Getty, Alzheimer's Association, U.S, CNBC, Alzheimer's, Novo Nordisk's, Ave Locations: Provo , Utah, Danish, Philadelphia, Biogen, Novo, Bartlett , Tennessee, U.S

☆ Takeaways from the RNC’s first day
▼ + stars: | 2024-07-15 | by ( Eric Bradner | ) edition.cnn.com time to read: +9 min

Trump called Vance 20 minutes before he announced he’d chosen the Ohio senator on Truth Social, a source familiar with the process told CNN. The two had met at Trump’s Mar-a-Lago club on Saturday, before the rally at which Trump was shot in the ear. Trump is betting that Vance articulating his evolution from Trump critic to supporter will prove much more potent than those older comments. “President Trump honored the Constitution. “I’m here tonight to tell you, no matter your political background, the best chance we have to give our babies a better life is to elect Donald Trump president of the United States,” Rose said.

Persons: Donald Trump, Trump, Ohio Sen, JD Vance, “, ”, Vance, Joe Biden, Vance Rather, he’d, Mike DeWine, CNN Vance, rans, Kristi Noem, she’d, Glenn Youngkin, Elise Stefanik, —, Byron Donalds, “ Donald Trump, South Carolina Sen, Tim Scott, ” Scott, Van Jones, Sean O’Brien, O’Brien, ” O’Brien, Biden, Amber Rose, influencer, ” Rose, CNN Ron Johnson’s Ron Burgundy, Wisconsin Sen, Ron Johnson’s, ” Johnson’s Organizations: CNN, Republican National Convention, Secret Service, Republican, reelecting, Truth, Trump’s, ”, ” Ohio Gov, Republican Party, Trump, Republicans, ” Publicly, Trump —, South Dakota Gov, Virginia Gov, New, New York, Democratic, Florida Rep, International Brotherhood, Teamsters, Labor, CNN Trump, Biden, White House, Donalds, Black Republicans Locations: Milwaukee, Butler , Pennsylvania, Ohio, Pennsylvania, Wisconsin, ” Ohio, Ohio’s, Florida, South Carolina, American, Washington, Michigan , Pennsylvania, United States

Diplomats and officials who spoke with CNN said Rutte is seen as a staunch trans-Atlanticist and a consensus builder. “He is really a seasoned political official, and this is essential to keep the cohesion of the alliance,” a European official said. “It was just a very polite, slightly humorous way of dealing Trump, and Trump appreciated it,” Hoekstra recalled to CNN. “We are not there yet, but it is better than when Trump left,” the official told CNN. Biden likes Rutte personally, they get along well, and the US president sees them as sharing the same values, the official told CNN.

Persons: Donald Trump, Trump, Mark Rutte, Jens Stoltenberg, Rutte, ”, “ Trump, Pete Hoekstra, ” Hoekstra, ‘ Touche, ’ ”, “, ” Rutte, Stoltenberg, Joe Biden, Biden, “ Rutte, Putin Organizations: CNN, NATO, Dutch, Diplomats, Trump, Kyiv – Locations: Washington, NATO, Russia, Netherlands, European, Europe, Ukraine, China, US, ”

In addition to Wegovy and Ozempic, the GLP-1 class includes Eli Lilly's highly popular weight loss drug Zepbound and diabetes treatment Mounjaro. VanGilder signed up nearly four years ago and started taking the weekly diabetes injection Ozempic specifically for weight loss. The big difference between Calibrate and prior weight loss efforts, VanGilder said, is that she doesn't feel like she's dieting. Calibrate is one of the only companies to regularly release reports detailing the results of its weight loss program. The federal Medicare program by law can't cover weight loss drugs unless the prescription is for another approved health benefit, such as diabetes or cardiovascular health.

Persons: Michael Siluk, Gray Beard, She'd, that's, Beard, wouldn't, She's, Ro, Goldman Sachs, Eli Lilly's, it's, Andrew Dudum, There's, Zachariah Reitano, Reitano, Wegovy, WeightWatchers, Gary Foster, Foster, Oprah Winfrey's, Kim Gradwell, Lee Smith, Jennifer VanGilder, she'd, Jenny Craig, VanGilder, I've, Kristin Baier, Rob MacNaughton, Ro's Reitano, we'd, Eli Lilly, Craig Primack, Primack, Hims, Dudum, We're Organizations: — Novo, UCG, Novo Nordisk, CNBC, Teladoc Health, World Health Organization, Food, WeightWatchers Clinic, Ursinus College, Asset Management Locations: Charlotte , North Carolina, U.S, Dudley , North Tyneside, Britain, Collegeville , Pennsylvania, Hims

☆ AstraZeneca targets $80 billion in total revenue by 2030 in 'post-Covid era'
▼ + stars: | 2024-05-21 | by ( Sophie Kiderlin | In | ) www.cnbc.com time to read: +2 min

Costfoto | Future Publishing | Getty ImagesLONDON — Pharmaceutical company AstraZeneca on Tuesday said it planned to increase its total revenue to $80 billion by 2030 — up 75% from $45.8 billion in 2023. AstraZeneca will focus on its oncology, biopharmaceuticals and rare diseases businesses and expects to release an additional 20 medicines in the next six years. "Many of them have the potential to be $5 billion drugs," Sarin noted. A company statement detailed that this revenue figure could be hit annually for many of the new medicines in peak years. "For the entire market to get replaced it will take time, but we think we have the technology today to start replacing them," Sarin told CNBC.

Persons: CNBC's Arabile Gumede Organizations: Astrazeneca, Artificial Intelligence, — Pharmaceutical, AstraZeneca, CNBC, U.S . FDA, Pharmaceuticals, Investments Locations: Shanghai, China, Europe, London, Singapore

☆ Read the Texas Governor’s Pardon
▼ + stars: | 2024-05-16 | by ( ) www.nytimes.com time to read: +2 min

PROCLAMATION BY THE Governor of the State of Texas PROCLAMATION No. 2024-0001 DPS #07666731 TO ALL TO WHOM THESE PRESENTS SHALL COME: WHEREAS, Daniel Scott Perry, TDCJ #02450686, D.O.B. April 24, 1987, was sentenced in the 147th District Court in Travis County on May 10, 2023, to twenty- five years in prison for the offense of Murder, Cause No. D-1-DC-21-900007; and WHEREAS, the Texas Board of Pardons and Paroles has conducted an exhaustive review of Daniel Scott Perry's personal history and the facts surrounding his shooting of Garrett Foster; and WHEREAS, both the Second Amendment to the United States Constitution and Article I, Section 23, of the Texas Constitution protect the right to keep and bear arms for, among other things, self-defense; and WHEREAS, Texas law, consistent with those constitutional guarantees, provides one of the clearest self-defense protections in the United States; and WHEREAS, Texas Penal Code § 9.32(a) provides that a person “is justified in using deadly force against another" when that person "reasonably believes the deadly force is immediately necessary" to protect a person against another's use of unlawful deadly force; and WHEREAS, Texas Penal Code § 9.32(c) provides that a person who is otherwise lawfully present at the location where deadly force is used "is not required to retreat before using deadly force"; and WHEREAS, on July 25, 2020, Daniel Scott Perry, while driving on a public road in Austin, slowed his vehicle as he rounded a corner onto Congress Avenue and encountered a group of protestors obstructing traffic; and WHEREAS, Daniel Scott Perry's car was immediately surrounded by aggressive protestors who rushed to obstruct, strike, pound, smash, and kick his vehicle; and WHEREAS, Garrett Foster then approached within 18 inches of Daniel Scott Perry's car, confronted him, and brandished a Kalashnikov-style rifle in the low-ready firing position; and WHEREAS, Daniel Scott Perry fired his handgun at Garrett Foster to eliminate a perceived threat to his safety and called law enforcement less than one minute later to inform them of the incident; and WHEREAS, Daniel Scott Perry explained to law enforcement at the time that he used his weapon because he feared losing his life and has since consistently stated that he acted in self-defense; and WHEREAS, Travis County District Attorney José Garza, rather than upholding the self- defense rights of citizens, has prioritized "reducing access to guns" that citizens may use to lawfully defend themselves; and FILED IN THE OFFICE OF THE SECRETARY OF STATE 1:25 PM O'CLOCK MAY 16 2024

Persons: Daniel Scott Perry, Paroles, Daniel Scott Perry's, Garrett Foster, brandished, Attorney José Garza Organizations: D.O.B, Texas, United States Constitution, Travis, Attorney Locations: Texas, TDCJ, Travis County, United States, Austin

☆ Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
▼ + stars: | 2024-05-07 | by ( Scott Olson | Getty Images | ) www.cnbc.com time to read: +10 min

Amgen is among the leaders of a pack of drugmakers racing to join the market with their own weight loss treatments. Amgen's drug, MariTide, is taken less frequently than Novo Nordisk's Wegovy and Eli Lilly's Zepbound, and may cause longer-lasting weight loss than the market leaders' injections. Novo Nordisk and Eli Lilly are also working on new weight loss drugs. The competition for a slice of the weight loss market has only grown more fierce in recent months. An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023.

Persons: NOVO.B, Scott Olson, Eli Lilly, Nordisk's Wegovy, Eli Lilly's Zepbound, Amgen, William Blair, Matt Phipps, Bob Bradley, Boehringer Ingelheim, Phipps, Zepbound, Chris Schott, MariTide, Mario Tama, he's, Eli Lilly drugs, CagriSema, Eli Lilly’s, Brendan McDermid, Boehringer, Ingelheim, survodutide, Pascal Soriot, Christopher Furlong, dealmaking, David Denton Organizations: New, Halstead Pharmacy, Getty, Novo Nordisk, Nordisk's, William Blair & Company, CNBC, Therapeutics, AstraZeneca, Zealand Pharma, MariTide, Reuters, GLP, Pfizer, Eccogene Locations: Chicago , Illinois, Novo, Amgen, Thousand Oaks , California, New York City, U.S, Zealand, Macclesfield

☆ Most people on weight loss drugs are spending less on restaurants and takeout, survey says
▼ + stars: | 2024-04-20 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +4 min

Most people taking those medications, called GLP-1s, say they are spending less on eating out at restaurants and ordering takeout, according to a Morgan Stanley survey released on Tuesday. GLP-1s include Novo Nordisk 's blockbuster weight loss injection Wegovy and diabetes counterpart Ozempic, along with Eli Lilly 's popular weight loss treatment Zepbound and diabetes injection Mounjaro. "There is growing evidence that the drugs have a meaningful impact on consumer behavior and spending on groceries and restaurants," Morgan Stanley analysts said in the survey. Those people are "early in their weight loss journey," but are making substantial changes to their diets and spending, according to the firm. Roughly half of people reported cutting consumption of regular sodas, alcohol and salty snacks by 50% or more since starting on weight loss drugs.

Persons: —, Morgan Stanley, Eli Lilly, Hollie Adams, Reuters Morgan Stanley, Morgan Stanley survery Organizations: Washington Post, Novo Nordisk, Reuters, Consumers Locations: Manhattan, London, Britain

☆ Taylor Swift's new album features 2 high-profile guest stars — and they both stand to reap major rewards
▼ + stars: | 2024-04-19 | by ( Kwan Wei Kevin Tan | ) www.businessinsider.com time to read: +1 min

Taylor Swift's latest album features collaborations with Post Malone and Florence and The Machine. Swift has worked with artists as varied as B.o.B, Bon Iver, and Ed Sheeran. download the app Email address Sign up By clicking “Sign Up”, you accept our Terms of Service and Privacy Policy . AdvertisementTaylor Swift's album "The Tortured Poets Department" is here, and it features two heavy-hitting collaborations. Swift's 11th studio album features the rapper Post Malone on the song "Fortnight" and the English indie rock band Florence and The Machine on "Florida!!!."

Persons: Taylor Swift's, Post Malone, Swift, Bon Iver, Ed Sheeran, —, Taylor, Swift's, I've Organizations: Service, Department, Business Locations: Florence, Bon, Florida

☆ Analysis: Can Netanyahu avoid triggering a regional war?
▼ + stars: | 2024-04-16 | by ( Nic Robertson | ) edition.cnn.com time to read: +6 min

In a paradigm shift after decades of shadow proxy war, Tehran is usurping Israel’s strategy. “We have decided to create a new equation,” Iran’s Islamic Revolutionary Guard Corps (IRGC) Commander Hossein Salami said. When faced with existential threats in the past, Israel has executed the most audacious raids the region has ever witnessed. The damage that can be inflicted on Iran is huge, is huge.”So the most important question right now must be, can Netanyahu read the room right – with Iran threatening to attack, allies warning him not to – and avoid triggering a regional war. Iran, he implied, won’t attack Israel as long as it fears America’s reaction.

Persons: CNN —, Joe Biden’s, Ebrahim Raisi’s, ” Israel, Hossein, “, Bashar al, Israel, Benjamin Netanyahu, Yoav Gallant, Benny Ganz –, David Barnea, Staff Herzi Halevi, Netanyahu, Bezalel Smotrich, of National Security Itamar Ben, Gvir, Ganz, Gallant, – Ganz, ” Netanyahu, ” Netanyahu’s, Saleh Al, Amos Yadlin, Yadlin, ” Yadlin, Bashar, Iran’s, Mohammad Reza Zahedi, Biden Organizations: CNN, Islamic Revolutionary Guard Corps, –, Staff, of National Security, IDF’s Military Intelligence, UN Security Locations: CNN — Israel, Israel, Iran, Tehran, Osirak, Syria, Tel Aviv, Gaza, Lebanese, Beirut, Lebanon, Damascus, America

☆ Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
▼ + stars: | 2024-03-16 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +12 min

The blockbuster drug — one of a handful of weight loss treatments to skyrocket in popularity over the last year — is now approved in the U.S. for heart health, too. The spokesperson added that state Medicaid programs would be required to cover Wegovy for its new cardiovascular use. But Gremminger said the standard of care for the long-term use of weight loss drugs is "in flux." State employees will no longer have insurance coverage for GLP-1s when used for weight loss at the beginning of next month. Both drugmakers have launched programs to help patients, with or without commercial insurance coverage, afford their weight loss treatments.

Persons: Klesty, John Crable, Wegovy, Jaime Almandoz, Joe Buglewicz, Shawn Gremminger, Hartley, Gremminger, Dale Folwell, We've, Folwell, Phelan M, Eli Lilly, Ceci Connolly, Julie Stich Organizations: Reuters, Novo Nordisk, CNBC, Medicare, Services, FDA, CVS, Aetna, International Foundation of Employee, Drug Administration, University of Texas Southwestern Medical Center, Washington Post, Getty, National Alliance of Healthcare, Taft, Nordisk, Nordisk's Ozempic, GOP, Carolina, Republican Governors Association, AP, Alliance of Community Health, U.S . Health, IFEBP, BMI Locations: U.S, Novo, Dallas, North Carolina, Orlando , Florida

☆ Thinking about taking new weight loss drugs? These are the big health risk decisions that will follow
▼ + stars: | 2024-02-28 | by ( Eric Rosenbaum | ) www.cnbc.com time to read: +6 min

In this article NOVO.B-DKLLYWWGWW Follow your favorite stocks CREATE FREE ACCOUNTAn injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. But will Americans trust the most iconic brand in the legacy weight-loss business to guide them into its future? "Big pharma was coming for weight loss, and if they didn't have a clinical angle, they would have run the risk of becoming an irrelevant company." "This is a new, incredibly powerful and effective class of pharmaceuticals that a lot of people will find help improve their health." watch nowRisks of overreliance on obesity drugs The risk is real that providers may use the medications and "forget about lifestyle," said John Batsis, an associate professor and nutrition expert at the University of North Carolina Chapel Hill's school of public health.

Persons: Eli Lilly’s, Brendan Mcdermid, Eli Lilly, —, Sima Sistani —, Sistani, Alex Fuhrman, Hallum, Fuhrman, Davidson, Linda Bolton Weiser, I've, Geoff Cook, Cook, John Batsis, Batsis Organizations: Reuters, Novo Nordisk, CNBC, Craig, pharma, University of North, University of North Carolina Chapel Locations: New York City, U.S, Herbalife, University of North Carolina

☆ Unpredictable Strongman? Two Years Into War, Putin Embraces the Image.
▼ + stars: | 2024-02-23 | by ( Anton Troianovski | ) www.nytimes.com time to read: 1 min

After President Biden called President Vladimir V. Putin of Russia a “crazy S.O.B.” this week, the Kremlin was quick to issue a stern condemnation. But the image of an unpredictable strongman ready to escalate his conflict with the West is one that Mr. Putin has fully embraced after two years of full-scale war. At home, the Kremlin is maintaining the mystery over the circumstances of the death last week of Aleksei A. Navalny, preventing the opposition leader’s family from reclaiming his body. In Ukraine, Mr. Putin is pressing his army to maintain its brutal offensive, boasting on television that he stayed up all night as the city of Avdiivka fell to Russian forces.

Persons: Biden, Vladimir V, Putin, Aleksei A Organizations: Kremlin Locations: Russia, Ukraine, Avdiivka, Russian

☆ Biden Called Putin a ‘Crazy S.O.B.’ The Kremlin Called Biden a ‘Cowboy.’
▼ + stars: | 2024-02-22 | by ( Zolan Kanno-Youngs | More About Zolan Kanno-Youngs | ) www.nytimes.com time to read: +1 min

In a television interview, Mr. Putin said he thought he knew why Mr. Biden had lashed out. Mr. Putin said he believed Mr. Biden’s remark was a result of that endorsement. “If I stood here 10 to 15 years ago and said all this, you’d all think I should be committed,” Mr. Biden said. He added that Mr. Trump has been terrible for the Republican Party. That seems to be lost with some of the things this fellow has been saying,” Mr. Biden said of Mr. Trump.

Persons: Putin, Mr, Biden, Biden’s, “, ” Mr, Vladimir, Donald J, Trump, Aleksei A, they’ve Organizations: Republican Party, Mr Locations: U.S, In California, Russian, American

☆ Putin looms over a third successive US election
▼ + stars: | 2024-02-22 | by ( Stephen Collinson | ) edition.cnn.com time to read: +12 min

CNN —“Russia, Russia, Russia.”Ex-President Donald Trump’s scathing catch phrase for a torrent of investigations during his administration also serves as an apt catch-all for the current meltdown over Moscow roiling US politics. But Russia and its leader, whom President Joe Biden described as a “crazy S.O.B.” at a Wednesday fundraiser, won’t go away. All the ways Putin is playing in US politicsPutin is advancing Russian interests against the US on multiple fronts. Putin recently formalized his warming ties with North Korean tyrant Kim Jong Un by presenting him with a new limousine. The Russian leader was particularly incensed by the US-led operation to topple Libyan leader Moammar Gadhafi in 2011.

Persons: CNN —, ”, Donald Trump’s, Joe Biden, won’t, Vladimir Putin, Putin, Ukraine –, –, Alexander Smirnov, “, Trump, Smirnov, Biden, it’s, Putin can’t, ” Douglas, Alexey Navalny, Biden lambasts Trump, ” Biden, Volodymyr Zelensky, Ronald Reagan, Mikhail Gorbachev, he’s, he’d, Mike Turner, Ksenia, Paul Whelan –, Evan Gershkovich, Geopolitically, Kim Jong Un, George W, Bush, Barack Obama, Moammar Gadhafi, Hillary Clinton, Robert Mueller, “ We’ll, Mueller Organizations: CNN, Kremlin, United States, European NATO, ”, Moscow, House Republicans, GOP, CIA, NATO, Republican Party, Republicans, Republican, Trump, Marine, Wall Street, Putin, Biden, US, Democratic Locations: Russia, Moscow, United States, China, Soviet, East Germany, United, Ukraine, Russian, European, Washington, Asia, Sweden, Finland, Berlin –, Europe, Ukrainian, California, North Korea, Iran, Crimea, Helsinki, Geneva

☆ Biden calls Putin a ‘crazy S.O.B.’ and criticizes Trump’s Navalny comments during fundraiser
▼ + stars: | 2024-02-21 | by ( Samantha Waldenberg | ) edition.cnn.com time to read: +4 min

CNN —President Joe Biden called Russian President Vladimir Putin “a crazy S.O.B.” in a fundraiser Wednesday in San Francisco, according to the pool reporters traveling with the US president. But the existential threat to humanity is climate,” Biden told those gathered at the fundraiser. Biden also criticized former President Donald Trump’s comments likening his legal troubles to the death of Russian opposition leader and Kremlin critic Alexey Navalny. Where the hell does this comes from,” Biden said, according to reporters in the room. These guys do not believe in basic democratic principles,” Biden said according to the pool traveling with him.

Persons: Joe Biden, Vladimir Putin “, “, Putin, ” Biden, Biden, Donald Trump’s, Alexey Navalny, ”, Navalny, …, Trump, ” Trump, Dmitry Peskov, Strom Thurmond, “ I’ve, I’ve, “ You’ve, ‘ You’ve, Nancy Pelosi, John Doerr, CNN’s Kate Sullivan, Kaanita Iyer, Anna Chernova Organizations: CNN, Republican, NATO, Putin, Russia, Kremlin, Republicans, ”, White Locations: San Francisco, United States, Russia, U.S, United States of America, South Carolina, Los Altos Hills , California

☆ Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
▼ + stars: | 2024-02-10 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +8 min

Victoria Klesty | ReutersThe insatiable demand for weight loss drugs is trouncing supply, leaving many patients struggling to find the injectable treatments. The dominant weight loss drugmakers, Novo Nordisk and Eli Lilly , have said supply woes likely won't go away anytime soon, as the popularity of those medicines continues to soar. Some Wall Street analysts project that the weight loss drug market could be worth $100 billion by the end of the decade. But both Novo Nordisk and Eli Lilly gave updates on positive supply developments to investors over the last week. Other forms of weight loss drugs could helpAlternative forms of weight loss drugs could also help alleviate supply constraints in the future.

Persons: Victoria Klesty, Eli Lilly, Cantor Fitzgerald, Louise Chen, Nordisk's Wegovy, Eli Lilly's Zepbound, Goldman Sachs, Jeff Friedman, Novo, Mike Segar, Eli, Catalent, Yves Herman Yves Herman, TD Cowen, Michael Nedelcovych, Anat Ashkenazi, Cantor Fitzgerald's Chen, Morgan Stanley, Eli Lilly's, George Frey Organizations: Novo Nordisk, CNBC, Nordisk's, University of Florida, Pfizer, AstraZeneca, Roche, Food, Nordisk, Company, FDA, Novo Holdings, Wegovy, REUTERS, Reuters, U.S Locations: Oslo, Norway, Novo, U.S, Branchburg , New Jersey, Brussels, Belgium, Catalent, Concord , North Carolina, North, Germany, Indiana, Denmark, France

☆ Analysts predicted new obesity medicines would be blockbusters. Now they’re raising their forecasts
▼ + stars: | 2023-09-16 | by ( Christina Cheddar Berk | ) www.cnbc.com time to read: +9 min

Fernandez sees a total addressable market of $140 billion to support patients with obesity. He expects there is a potential for GLP-1 drugs to become as common and widely used, much like statins are used to lower cholesterol. Morgan Stanley's Flynn estimates a 30% share of the diabetes market would generate $109 billion on a worldwide basis for GLP-1 drugs. Layer in a 15% to 30% share of the obesity market and that equates to worldwide sales of $97.4 billion to $194.8 billion. Guggenheim's estimates also assume that oral GLP-1 drugs that are currently in development are able to come to market a few years from now.

Persons: Seamus Fernandez, Fernandez, Lilly, Eli Lilly, Morgan Stanley, Terence Flynn, Eli Lilly's Mounjaro, Insulet, Canaccord, William Plovanic, Plovanic, It's, Morgan Stanley's Flynn, Flynn, Novo, Michael Bloom Organizations: Wall, Novo, American Heart Association, Food and Drug Administration, Novo Nordisk, Iqvia, Disease Control Locations: GLP

☆ Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here's what we know
▼ + stars: | 2023-09-10 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +7 min

Jaap Arriens | Nurphoto | Getty ImagesHeather Le Biller shed 9 pounds within the first week of taking Novo Nordisk 's blockbuster diabetes drug Ozempic – and then even more as she continued treatment. That means it could take years before the Food and Drug Administration and other regulators worldwide approve drugs like Ozempic and Wegovy as addiction treatments. Jerlhag and her colleagues at the University of Gothenburg in Sweden have studied the effect of GLP-1s on addictive behaviors for more than a decade. "The mechanism in the brain that regulates overeating is important in regulating addictive behaviors as well," Leggio told CNBC. Still, NIDA's Leggio advises against using GLP-1s off-label to reduce addictive behaviors, "simply because there's not enough evidence in humans that they work."

Persons: Jaap Arriens, Heather Le Biller, Ozempic –, Le Biller, they're, Angela Fitch, Brandon Bell, Dr, Lorenzo Leggio, semaglutide, –, Eli Lilly, pharmacologist, Jerlhag, George Frey, NIDA's, Leggio, Steven Batash, Batash, NIDA's Leggio Organizations: Nurphoto, Novo Nordisk, CNBC, Wegovy, Obesity Medicine Association, and Drug Administration, Pharma, National Institute on Drug, University of Gothenburg, Company, Reuters, Brigade, Getty Locations: Riga, Latvia, France, Ozempic, Novo, U.S, Italian, Austin , Texas, Sweden, Provo , Utah, Queens , New York

☆ Big pharma's blockbuster obesity drug battle is just getting started, and it's headed for $100 billion
▼ + stars: | 2023-09-09 | by ( Bob Woods | ) www.cnbc.com time to read: +13 min

In this article LLYNOVO.B-DK Follow your favorite stocks CREATE FREE ACCOUNTOzempic drug to treat diabetes. Since Wegovy and Mounjaro have been on the market, "neither company can make the drug fast enough," she said. The Food and Drug Administration approved Ozempic in 2017 for diabetes and Wegovy in 2021 to treat obesity. Mounjaro, introduced in 2022 to treat diabetes, contains GLP-1, plus GIP, a similar appetite suppressor that can lead to weight loss. Coverage for Mounjaro ($1,023 per month) to treat diabetes varies based on an individual's insurance plan and drug benefits.

Persons: Eli Lilly, Novo's, Lilly's, Emily Field, Lilly, David Ricks, CNBC's Jim Cramer, Ozempic, Novo, Mounjaro, George Frey, Lars Fruergaard Jorgensen, Wajahat Mehal, Tom Carper, Bill Cassidy of, We've, Camilla Sylvest, there's, Sylvest, Cowen, What's, It's, Mike Mason, Amgen, Emmanuel Papadakis Organizations: Novo Nordisk, Pfizer, Amgen, Barclays, Nordisk, Drug Administration, Mounjaro, SVB Securities, Food and Drug Administration, Pharmacy, Reuters Novo, Novo, Wegovy, European Union, Medicare, Yale School, Metabolic, Congressional Black Caucus, CDC, pharma, American Medical Association, , Big Pharma, American Diabetes Association, Deutsche Bank Locations: Lilly, Denmark, Provo , Utah, U.S, European, Delaware, Bill Cassidy of Louisiana, Novo, Kalundborg, Hillerød, Boone County , Indiana

☆ Weight loss drugs boost sales at retail pharmacies, but they may not help profits much
▼ + stars: | 2023-08-21 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +5 min

George Frey | ReutersDrugmakers aren't the only ones feeling the impact of the weight loss industry gold rush. Retailers with pharmacy businesses, such as Walmart , Kroger and Rite Aid , said increased demand for prescription weight loss drugs helped boost sales for the second quarter. Are weight loss drugs profitable? A selection of injector pens for the Saxenda weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. For one, branded drugs don't directly compete with other medications because they have patent protections.

Persons: George Frey, Reuters Drugmakers, Arun Sundaram, it's, Elon Musk, Eli Lilly, Doug McMillon, Matthew Schroeder, Schroeder, Rodney McMullen, CFRA Research's Sundaram, Michael Lasser, Jim Vondruska, USC's Schaeffer Organizations: KR NOVO.B, Novo Nordisk, Pharmacy, Reuters, Walmart, Kroger, Rite, CFRA Research, CNBC, Nordisk, Elon, Pfizer, UBS, USC's, USC's Schaeffer Center for Health, Association Locations: Provo , Utah, U.S, GLP, Chicago , Illinois

☆ Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health data
▼ + stars: | 2023-08-09 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +8 min

There is likely a long way to go before the U.S. sees increased insurance coverage for obesity drugs. While the trial results demonstrate that obesity drugs may have significant health benefits beyond shedding unwanted pounds, organizations representing U.S. insurers emphasized that the data is still preliminary. "Health insurance providers will continue to analyze new evidence as it becomes available," he added. Ceci Connolly, CEO of the Alliance of Community Health Plans, acknowledged the promise of the data but said "outrageous prices should give everyone pause." The organization represents regional, community-based health plans that cover more than 18 million Americans across the U.S.

Persons: Jim Vondruska, Wegovy, Eli Lilly, David Allen, Ceci Connolly, Jared Holz, It's, Debra Tyler's, Joe Buglewicz, Eduardo Grunvald, George Frey, UCSD's Gunvald, Eli, Ethan Lazarus, Lazarus Organizations: Reuters Novo Nordisk, Novo Nordisk, America's Health, Alliance of Community Health, U.S, Drugs, Pfizer, Medicare, CVS, Aetna, CNBC, Washington Post, Getty, UCSD Health's Center, International Foundation of Employee, University of Texas System, UTS, Novo, Reuters, Obesity Medicine Association, New England, of Medicine Locations: Chicago , Illinois, U.S, Mizuho, Killingworth, Conn, Texas

Search resuls for: "O.B"

25 mentions found